8th of November 2010 Meta-IQ presented at the Nordic Venture Forum (NVF) 2010 in Copenhagen, Denmark.

Oktober and November 2010 Metabolistik Consulting closed important international collaboration contracts.

7th of September 2010 Meta-IQ presented at the semi finals of European Venture Contest (EEVC) 2010 in Aarhus, Denmark.

7th of September 2010 Metabolistik Consulting presented at the semi finals of European Venture Contest (EEVC) 2010 in Aarhus, Denmark.

31th of August 2010 Meta-IQ Prof. Eva Steiness presented the results of the independent Due Dilligence she performed on Meta-IQ with a positive result, where she recommends investment. The due dilligence was arranged by MTIC Aarhus Denmark.

1st of April 2010 Meta-IQ has moved to new inspiring office building at Augustenborggade 2, 1s, 8000 Aarhus C. Denmark.

27th of January 2010 Meta-IQ has presented its systemic thinking approach in the treatment of brain diseases at the Center for Psychiatric Research, Aarhus University Hospital Risskov Denmark. See presentation

2nd of January 2010 Meta-IQ Dr. Peter Heinrich has joined the Meta-IQ management team as Key Advisor Bibliography of Dr Peter Heinrich.

17th of August 2009 Meta-IQ has the first data showing a highly significant efficacy of MIQ-003 in the treatment of Multiple Sclerosis in a therapeutic animal model.

13th of July 2009 Meta-IQ Article in the Jylandsposten newspaper on Meta-IQ collabration with international and national research institutes and Universities. Read article here.

6th of July 2009 Meta-IQ has started the final proof of concept testing of M-IQ 003 in different Multiple sclerosis animal models

24th of June 2009 Meta-IQ presented at the Business Development Conference 2009 in Munich, Germany. See picture

5th of May 2009 Metabolistik: The US patent office decided to grant new US patent on fatty acid oxidation blockers in skin diseases.

23rd of April 2009 Meta-IQ is an invited speaker at the Anglonordic Biotech Conference in London. Meta-IQ will present in the Atlas Venture Investment Room

From 30th of March till 10th of April 2009 Meta-IQ is meeting with Venture capital companies in California.

29th of March 2009 Meta-IQ appoints Jette Nieland as the CEO and John Nieland as the COO of the company

4th of September 2008 Meta-IQ is at a private conference presented to the public

May 2008 Meta-IQ generated excellent preclinical data showing efficacy of its drug M-IQ 002 in Depression

April 2008 Meta-IQ generated excellent preclinical data showing efficacy of its drug M-IQ 001 in restoration of short and long term memory in an Alzheimer memory loss model